Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment
Clinical trial NCT03436199 · COMPLETED
Trial details
- NCT number
- NCT03436199
- Sponsor
- Adamas Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-29
- Primary completion
- 2019-12-10
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.